Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.98 +0.13 (+1.47%)
At close: Oct 22, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Non Operating Interest Expenses (2024 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) reported Non Operating Interest Expenses of $1.6 million for Q1 2026, up 450.2% from $289,931 a year earlier but down 74.4% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings posted Non Operating Interest Expenses of $8.53 million.

  • By year, Non Operating Interest Expenses came in at $97,988 in FY2024 (+992.9%) and $8,966 in FY2023.
  • Five-year quarterly Non Operating Interest Expenses spans a low of $183,310 in Q1 2024 and a high of $6.23 million in Q4 2025.
  • Per Business Quant data, the three quarters before Q1 2026 came in at $6.23 million (Q4 2025), $1.48 million (Q3 2025) and $527,893 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.60 Mn
Dec 31, 2025 6.23 Mn
Sep 30, 2025 1.48 Mn
Jun 30, 2025 527,893.00
Mar 31, 2025 289,931.00
Mar 31, 2024 183,310.00
API Access

Aspire Biopharma Holdings, Inc. Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ASBP&period=max&api_key=YOUR_API_KEY